Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67594872 | 6759487 | 2 | F | 20090331 | 20080813 | 20120424 | PER | PHEH2008US05459 | NOVARTIS | 0.00 | M | N | 0.00000 | 20090702 | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67594872 | 6759487 | 1 | PS | LOTENSIN | 1 | 5 MG ; 10 MG ; 20 MG ; 5 MG | 19851 | ||||||||||||
| 67594872 | 6759487 | 2 | C | LESCOL | 1 | 0 | |||||||||||||
| 67594872 | 6759487 | 3 | C | BETAPACE | 1 | 0 | |||||||||||||
| 67594872 | 6759487 | 4 | C | FLOMAX | 1 | 0 | |||||||||||||
| 67594872 | 6759487 | 5 | C | ARICEPT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 67594872 | 6759487 | 1 | CARDIAC DISORDER |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 67594872 | 6759487 | OT |
| 67594872 | 6759487 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 67594872 | 6759487 | BLOOD POTASSIUM INCREASED | |
| 67594872 | 6759487 | DIZZINESS | |
| 67594872 | 6759487 | HYPOTENSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 67594872 | 6759487 | CSM |
Therapies reported
| no results found |